Definium Therapeutics Inc. Common Shares vs Super Group (SGHC) Limited Ordinary Shares — how do they compare? Definium Therapeutics Inc. Common Shares trades at $35.45 (market cap $4.59B), while Super Group (SGHC) Limited Ordinary Shares trades at $11.45 (market cap $5.86B). The key difference: Super Group (SGHC) Limited Ordinary Shares is the larger of the two by market cap, and Super Group (SGHC) Limited Ordinary Shares pays a 1.73% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and Super Group (SGHC) Limited Ordinary Shares for 0 Days on average.
| DFTX | SGHC | |
|---|---|---|
Market Cap | $4.59B | $5.86B |
Volume | 2,103,937 | 1,905,788 |
Sector | Health | Consumer Cyclical |
52-Week High | $48.45 | $15.59 |
52-Week Low | $10.68 | $8.52 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $3.55B | $5.41B |
Dividend Yield | — | 1.73% |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →Super Group (SGHC) Limited is a holding company for online sports betting and gaming businesses, operating the Betway sports betting brand and the Spin multi-brand online casino portfolio across markets in Europe, the Americas, and Africa.
Read more on SGHC →